TY - JOUR
T1 - New neuromuscular blocking drugs
AU - Coursin, Douglas B.
AU - Prielipp, Richard C.
AU - Murray, Michael J.
PY - 1995/10/26
Y1 - 1995/10/26
N2 - To the Editor: We congratulate Dr. Hunter (June 22 issue)1 on her timely review. It must be emphasized, however, that neuromuscular blocking drugs should be used only by practitioners who are skilled in airway management and respiratory support, and only after sufficient sedation and analgesia have been provided to patients, since these drugs are intrinsically devoid of any sedative, analgesic, or amnestic properties.2 To Hunter's description of the ideal neuromuscular blocking drug we would add that it should not interact with other drugs. Drugs known to potentiate the action of neuromuscular blockers include inhaled anesthetic agents, antibiotics (especially aminoglycosides), antiarrhythmic.
AB - To the Editor: We congratulate Dr. Hunter (June 22 issue)1 on her timely review. It must be emphasized, however, that neuromuscular blocking drugs should be used only by practitioners who are skilled in airway management and respiratory support, and only after sufficient sedation and analgesia have been provided to patients, since these drugs are intrinsically devoid of any sedative, analgesic, or amnestic properties.2 To Hunter's description of the ideal neuromuscular blocking drug we would add that it should not interact with other drugs. Drugs known to potentiate the action of neuromuscular blockers include inhaled anesthetic agents, antibiotics (especially aminoglycosides), antiarrhythmic.
UR - http://www.scopus.com/inward/record.url?scp=0028821855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028821855&partnerID=8YFLogxK
U2 - 10.1056/NEJM199510263331716
DO - 10.1056/NEJM199510263331716
M3 - Letter
C2 - 7565965
AN - SCOPUS:0028821855
SN - 0028-4793
VL - 333
SP - 1155
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 17
ER -